Our bodies naturally produce GLP-1, an incretin hormone, in response to food intake
The key difference is that tirzepatide is FDA-approved and commercially available as Mounjaro and Zepbound (~$1,000$1,100/month cash, or $25+ with insurance and savings cards)
Compounding may be considered in situations such as: Compounded medications are prepared for individual patients and are not mass-produced
By mimicking the hormone GLP-1, these drugs signal the brain to increase satiety, but they also influence the secretory and motor functions of the gut
In exogenous research applications, the synthetic BPC-157 fragment has been evaluated across tissue types spanning the entire musculoskeletal system, gastrointestinal tract, liver, pancreas, cardiovascular system, and central nervous system producing consistently positive results across an unusually wide range of injury and dysfunction models
The mean (SD) receptor occupancy for the GLP-1 receptor in the pancreas obtained for SAR425899 at a dose of 0.2 mg was 49.9 (13.3)%